Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations
- PMID: 1815069
- DOI: 10.1002/jps.2600801206
Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations
Abstract
The pharmacokinetics of sulpiride in plasma, red blood cells (RBC), and urine were investigated after administration of 100 mg by the iv route to 15 subjects and by the im route to 12 subjects. The concentrations of sulpiride in plasma, RBC, and urine were measured by HPLC. All the data were consistent with a two-compartment, open-body model. After iv administration, the mean +/- SD apparent elimination half-life of sulpiride was 6.47 +/- 1.00 h, and the mean +/- SD volume of distribution at steady state was 0.94 +/- 0.23 L/kg. Renal clearance (119.5 +/- 28.2 mL/min) was very close to total clearance (127.8 +/- 26.2 mL/min). In urine, the mean +/- SD recovery in form of the unchanged drug was 90.0 +/- 9.68% of the administered dose, and the excretion rate versus time showed an elimination half-life similar to that found in plasma. The values of all these parameters were very close to those obtained after im administration. The sulpiride partition coefficient between RBC and plasma did not show any significant change as a function of time and concentration, with a mean value +/- SD of 1.00 +/- 0.043, indicating that sulpiride is evenly distributed between RBC and plasma. The pharmacokinetic parameters determined from the plasma and the RBC data were similar.
Similar articles
-
Sulpiride pharmacokinetics in humans after intramuscular administration at three dose levels.J Pharm Sci. 1984 Aug;73(8):1128-36. doi: 10.1002/jps.2600730826. J Pharm Sci. 1984. PMID: 6491918
-
Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans.J Pharm Sci. 1992 Jan;81(1):26-32. doi: 10.1002/jps.2600810106. J Pharm Sci. 1992. PMID: 1619566
-
Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.Clin Pharmacokinet. 1989 Nov;17(5):367-73. doi: 10.2165/00003088-198917050-00005. Clin Pharmacokinet. 1989. PMID: 2582694
-
The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.Eur J Clin Pharmacol. 1980 May;17(5):385-91. doi: 10.1007/BF00558453. Eur J Clin Pharmacol. 1980. PMID: 7418717
-
Pharmacokinetics of meloxicam in red-eared slider turtles (Trachemys scripta elegans) after single intravenous and intramuscular injections.Am J Vet Res. 2016 May;77(5):439-44. doi: 10.2460/ajvr.77.5.439. Am J Vet Res. 2016. PMID: 27111010 Clinical Trial.
Cited by
-
Development of a physiologically-based pharmacokinetic model of the rat central nervous system.Pharmaceutics. 2014 Mar 18;6(1):97-136. doi: 10.3390/pharmaceutics6010097. Pharmaceutics. 2014. PMID: 24647103 Free PMC article.
-
Psychotherapeutic drug-induced life-threatening arrhythmias: A retrospective analysis using the Japanese adverse drug event report database.J Arrhythm. 2023 Oct 3;39(6):928-936. doi: 10.1002/joa3.12936. eCollection 2023 Dec. J Arrhythm. 2023. PMID: 38045460 Free PMC article.
-
Pharmacokinetics of levosulpiride after single and multiple intramuscular administrations in healthy Chinese volunteers.Acta Pharm Sin B. 2014 Oct;4(5):402-7. doi: 10.1016/j.apsb.2014.06.001. Epub 2014 Jul 3. Acta Pharm Sin B. 2014. PMID: 26579410 Free PMC article.
-
A risk-benefit assessment of sulpiride in the treatment of schizophrenia.Drug Saf. 1996 May;14(5):288-98. doi: 10.2165/00002018-199614050-00003. Drug Saf. 1996. PMID: 8800626 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources